VMI
VHCP Management III Portfolio holdings
AUM
$504M
This Quarter Return
+34.01%
1 Year Return
+678.37%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$214M
AUM Growth
+$214M
(+25%)
Cap. Flow
+$50.3M
Cap. Flow
% of AUM
23.47%
Top 10 Holdings %
Top 10 Hldgs %
93.72%
Holding
17
New
1
Increased
4
Reduced
8
Closed
–
Top Buys
1 |
Milestone Pharmaceuticals
MIST
|
$56.1M |
2 |
Axsome Therapeutics
AXSM
|
$14M |
3 |
Protagonist Therapeutics
PTGX
|
$3.19M |
4 |
LJPC
La Jolla Pharmaceutical Company
LJPC
|
$2.3M |
5 |
RARX
Ra Pharmaceuticals, Inc. Common Stock
RARX
|
$2.27M |
Top Sells
1 |
TCDA
Tricida, Inc. Common Stock
TCDA
|
$14.2M |
2 |
KalVista Pharmaceuticals
KALV
|
$7.37M |
3 |
KDMN
Kadmon Holdings, Inc.
KDMN
|
$1.99M |
4 |
ORTX
Orchard Therapeutics plc American Depositary Shares
ORTX
|
$1.89M |
5 |
BioCryst Pharmaceuticals
BCRX
|
$1.34M |
Sector Composition
1 | Healthcare | 96.88% |